Reset filter
Palabras clave
On-Study Form ×
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
    1. 7.1. Anestesiología
    1. 7.2. Dermatología
    1. 7.3. ENT
    1. 7.4. Geriatría
    1. 7.5. Ginecología / Obstetricia
    1. 7.6. Medicina Interna
      1. Hematología
      1. Enfermedades infecciosas
      1. Cardiología / Angiología
      1. Neumología
      1. Gastroenterología
      1. Nefrología
      1. Endocrinología / Enfermedades metabólicas
      1. Reumatología
    1. 7.7. Neurología
    1. 7.8. Oftalmología
    1. 7.9. Cuidados paliativos
    1. 7.10. Patología / Forense
    1. 7.11. Pediatría
    1. 7.12. Psiquiatría / Psicosomática
    1. 7.13. Radiología
    1. 7.14. Cirugía
      1. Cirugía General / Visceral
      1. Neurocirugía
      1. Cirugía plástica
      1. Cirugía Torácica
      1. Traumatología / Ortopedia
      1. Cirugía vascular
    1. 7.15. Urología
    1. 7.16. Odontología / OMS
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

191 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Stroke Impact Scale (SIS): PaReSiS UKH

- 5/12/16 - 1 formulario, 9 itemgroups, 60 items, 2 idiomas
Itemgroups: 33. physical difficulties, 34. Memory and ability to think, 35. Mood and Feelings, 36.Communicating and understanding, 37. Everyday activities, 38. Mobility, 39. Ability to use the hand most influenced by stroke, 40. Ability to do things, that give life a meaning, 41. Recovery from stroke
Stroke Impact Scale (SIS): PaReSiS UKH Rehabilitation Study: "Partizipatives Rehabilitationsprozessmanagement, PaReSiS Schlaganfall in Sachsen-Anhalt" Martin-Luther-Universität Halle-Wittenberg Medizinische Fakultät Institut für Gesundheits- und Pflegewissenschaft Projekt: Partizipatives Rehabilitationsprozessmanagement „Schlaganfall in Sachsen-Anhalt“ Magdeburger Straße 8 06097 Halle (Saale), Germany E-Mail: paresis@medizin.uni-halle.de

On-Study Form Bladder Cancer NCT00014534 CALGB-90104

- 21/8/15 - 1 formulario, 3 itemgroups, 61 items, 1 idioma
Itemgroups: Muscle Invasive Bladder Disease: Prior Treatment Affecting the Bladder, Prior Therapy Date, CCRR MODULE
On-Study Form Bladder Cancer NCT00014534 CALGB-90104 NCT00014534 NCI Cooperative Group On-Study Form-Revised (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6E9C-942E-7181-E034-0003BA12F5E7

On-Study - Superficial Bladder Cancer - On-Study Form - 2019333v2.31 - Superficial Bladder Cancer - On-Study Form

- 8/1/15 - 1 formulario, 5 itemgroups, 43 items, 1 idioma
Itemgroups: CRF Header, BLADDER: FORM ADMINISTRATION, BLADDER: DISEASE DESCRIPTION FOR SUPERFICIAL BLADDER CARCINOMA, SUPERFICIAL BLADDER DISEASE: PRIOR TREATMENT AFFECTING THE BLADDER, Comments
Superficial Bladder Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A961-3FA4-E034-080020C9C0E0

On-Study - Palliative Treatment for Head and Neck Cancer - On-Study Form - 2267713v3.0 - Palliative Treatment for Head and Neck Cancer - On-Study Form

- 20/9/21 - 1 formulario, 9 itemgroups, 85 items, 1 idioma
Itemgroups: CRF Header, Head & Neck: Form Administration, Head & Neck: Patient Assessment, Head & Neck: Disease Description - Initial Diagnosis of Disease, Head & Neck: Disease Description - Current Diagnosis, Head & Neck: Prior Health History - Palliative, Head & Neck: Prior Treatment - Systemic Therapy, Head & Neck: Prior Treatment - Radiation Therapy, Head & Neck: Prior Treatment - Surgery
Palliative Treatment for Head and Neck Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=20B9E4F5-9DD3-2343-E044-0003BA3F9857

On-Study - Muscle Invasive Bladder Cancer - On-Study Form - 2019331v2.31 - Muscle Invasive Bladder Cancer - On-Study Form

- 8/1/15 - 1 formulario, 5 itemgroups, 60 items, 1 idioma
Itemgroups: CRF Header, BLADDER: FORM ADMINISTRATION, BLADDER: DISEASE DESCRIPTION FOR MUSCLE INVASIVE BLADDER CANCER, MUSCLE INVASIVE BLADDER DISEASE: PRIOR TREATMENT AFFECTING THE BLADDER, Comments
Muscle Invasive Bladder Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A95D-3FA4-E034-080020C9C0E0

On-Study - Metastatic Bladder/Urothelial Cancer - On-Study Form - 2019330v2.31 - Metastatic Bladder/Urothelial Cancer - On-Study Form

- 8/1/15 - 1 formulario, 6 itemgroups, 55 items, 1 idioma
Itemgroups: CRF Header, BLADDER/UROTHELIAL: FORM ADMINISTRATION, BLADDER/UROTHELIAL: DISEASE DESCRIPTION FOR METASTATIC BLADDER/UROTHELIAL CANCER, BLADDER/UROTHELIAL: SITE(S) OF DISEASE, BLADDER/UROTHELIAL: PRIOR TREATMENT AFFECTING THE BLADDER/UROTHELIUM , Comments
Metastatic Bladder/Urothelial Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A95B-3FA4-E034-080020C9C0E0

Tolerability, pharmacokinetics, and brain Dopamine D3 receptor occupancy of increasing repeat doses of GSK618334 in healthy adults NCT01036061 - Visit Documentation 16

- 30/5/18 - 1 formulario, 13 itemgroups, 81 items, 1 idioma
Itemgroups: Date and Type of Visit, Vital Signs, ECG, Haematology, Clinical Chemistry, Urinalysis - Local, Urinalysis - Local: Dipstick Details, Urinalysis - Local: Microscopy Details, Pharmacokinetics Urine, Questionnaires, Meal, MRI Scan, PET Scan Baseline
Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Visit Documentation 16 Specification: PET Day-2-Day-1

Melanoma (Skin) NCT01274338 On-Study Form - Hematology/Chemistry On-Study Form Melanoma E1609 NCT01274338

- 25/3/15 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: Header, ON TREATMENT
E1609 Hematology/Chemistry Form Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery NCT01274338 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=97E7C12F-E851-FFC2-E040-BB89AD43160A

Bladder Cancer NCT00445601 On-Study - S0337 Cystoscopy and Urine Markers Form - 2389143v1.0 - S0337 Cystoscopy and Urine Markers Form

- 20/9/21 - 1 formulario, 4 itemgroups, 25 items, 1 idioma
Itemgroups: Header, Urine Markers, Cytoscopy, Comments
S0337 Cystoscopy and Urine Markers Form Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FE26193B-C3C0-4C67-E034-0003BA3F9857

On-Study Advanced Urinary Tract Cancer CALGB 90601 NCT00942331

- 30/7/15 - 1 formulario, 7 itemgroups, 65 items, 1 idioma
Itemgroups: Header Module, Initial Diagnosis, Bladder Malignant Neoplasm, Laboratory Values, Urinalysis, Prior Treatment - Systemic/Intravesical Regimens, Footer Module
CALGB 90601: On-Study Form NCT00942331 Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=653FC86F-74B9-C88B-E040-BB89AD432982

On-Study Form Advanced Melanoma E2603 NCT00110019

- 20/9/21 - 1 formulario, 7 itemgroups, 62 items, 1 idioma
Itemgroups: Header, Patient demographics, Data amendment, Description of Disease at Initial Diagnosis, History of Disease, Description of Current Disease, Comments
E2603 Advanced Melanoma On-Study Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma E2603 Advanced Melanoma On-Study Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E75E3DD6-DB7A-4ABA-E034-0003BA3F9857

Breast Cancer NCT01242800 On-Study - E2108 Step 2 On-Study Form - 3130597v1.0 - E2108 Step 2 On-Study Form

- 20/9/21 - 1 formulario, 8 itemgroups, 40 items, 1 idioma
Itemgroups: Header Module, Header, Amended Data, Patient Characteristics, Disease Description, Treatment Plan, Circulating Tumor Cell (CTC) Enumeration, Comments
E2108 Step 2 On-Study Form Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8E2EE15D-B7A5-69C7-E040-BB89AD431929

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial